Class Action Lawsuit Filed Against Reckitt Benckiser Group PLC

Strategic Insights -

Investors who purchased Reckitt Benckiser Group PLC securities between January 13, 2021, and July 28, 2024, may be eligible to join a class action lawsuit. The case alleges that the company made false and misleading statements about its business, operations, and prospects, specifically regarding the safety of its Enfamil formula for preterm infants. The complaint also alleges that defendants failed to disclose the attendant impact on Reckitt's sales and exposure to legal claims.

Key Takeaways:

  • A class action lawsuit has been filed against Reckitt Benckiser Group PLC alleging violations of federal securities laws.
  • The lawsuit seeks to recover damages on behalf of all persons and entities that purchased Reckitt securities between January 13, 2021, and July 28, 2024.
  • The complaint alleges that defendants made false and misleading statements about the company's business, operations, and prospects.
  • Specifically, the complaint alleges that defendants failed to disclose the risks of necrotizing enterocolitis (NEC) in preterm infants consuming Reckitt's Enfamil formula.
  • Investors have until August 4, 2025, to request Court appointment as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis, with no upfront costs.

Statistics:

  • January 13, 2021: Start date of the Class Period
  • July 28, 2024: End date of the Class Period
  • July 8, 2025: Date of the class action lawsuit filing
  • August 4, 2025: Deadline for investors to request Court appointment as lead plaintiff

Sources:

  • Newsfile Corp. - July 8, 2025
  • Bronstein, Gewirtz & Grossman LLC (bgandg.com/RBGLY)
  • LinkedIn, Twitter, Facebook, and Instagram accounts of Bronstein, Gewirtz & Grossman, LLC.